Executive Series 12 Dec 17: Viralytics (VLA) CEO & Managing Director, Dr Malcolm McColl
In this short video, Tom Piotrowski speaks with Viralytics (VLA) CEO & Managing Director, Dr Malcolm McColl about the company’s recent clinical trial results and plans for commercialisation of its CAVATAK drug.
YouTube Link: https://youtu.be/mixBVobIRd0
To view more Executive Series interviews, visit: https://www.commsec.com.au/market-news/executive-series
Executive Series: Viralytics (VLA) CEO & Managing Director, Dr Malcolm McColl
2min read
You might also like
Blue Chips & Stocks To Watch!
Top 30 shorted stocks
The technique of profiting from a price fall is called …
Trends & Opportunities
Gold Selloff Risk is High
Gold surged dramatically in recent weeks, powering higher to a …
Best Resources & Offers